Investment in Hyperthermics’ process to turn biowaste into energy and proteins
Farvatn Private Equity and Måsøval Eiendom have invested in the Norwegian biotechnology company Hyperthermics AS.…
20/06/2022 - 2 minutes
Norway
Norwegian Biotech Put on the Map with €18M Oncology Round
The immuno-oncology startup Cytovation has raised €17.7M (NOK 180M) in one of Norway's biggest Series…
26/01/2022 - 3 minutes
Biotech Investment in Norway: An Alternative Approach
Norway has not typically been an attractive region for biotech investors, so when Masha Strømme…
09/09/2020 - 6 minutes
This Biotech Links the Gut Microbiome to Diseases Using Norwegian Poo
In Norway’s capital city of Oslo, the biotech Bio-Me can rapidly screen for specific gut…
01/02/2019 - 4 minutes
Norwegian Pancreatic Cancer Vaccine Drastically Improves Survival
Targovax has obtained positive Phase I/II results showing its pancreatic cancer vaccine improved the survival…
25/05/2018 - 3 minutes
Bang and the Wart is Gone! Norwegian Peptide Destroys HPV-Infected Cells
Cytovation has raised over €3M to finish off pre-clinical testing of its treatment for warts, and…
08/01/2018 - 3 minutes
Christmas Has Come Early for Nordic Biotechs as a Norwegian Fund Readies €100M Injection
Hadean Ventures has closed its first fund, which it will begin to invest in life…
20/12/2017 - 2 minutes
Anti-Parasite Drug May Help to Treat Prostate Cancer, Say Norwegian Scientists
Researchers in Norway have found that a drug used to kill parasites like tapeworms can…
16/11/2017 - 3 minutes
Norwegian Biotech Announces Positive Phase I Results for T cell-Stimulating Vaccine
PCI Biotech's T cell-stimulating vaccine enhances the cellular immune response, supporting it as a candidate…
12/09/2017 - 2 minutes
A Norwegian Biotech is Aiming at Permanently Removing HPV Skin Infections
This week we're traveling to Bergen, a beautiful coastal city in Norway surrounded by seven…
07/07/2017 - 2 minutes
These Norwegian Biotech Execs are Bringing Back Cancer Vaccines & Oncolytic Viruses
We talked to CEO Øystein Soug and CMO Magnus Jäderberg of Targovax about why the…
03/07/2017 - 8 minutes
Norwegian Biotech Hits €21M in Private Placement for its Immunotherapies
Targovax has raised €21M (NOK200M) in a private placement, which the biotech will use to…
12/06/2017 - 2 minutes
